AHR and chronic kidney disease: Uremic toxins were found to suppress the Wnt/β-catenin pathway by augmenting AhR-mediated β-catenin ubiquitination and degradation in human dermal microvascular endothelial cells, which was also verified in adenine-induced CKD and IS solute-specific mouse models with hindlimb ischemia.